Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA029561-25
- Shipping:
- Calculated at Checkout
$324.00
Gene Name: IMPA2
Alternative Gene Name:
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000024525: 92%, ENSRNOG00000018516: 91%
Entrez Gene ID: 3613
Uniprot ID: O14732
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | WEECFQAAVQLALRAGQIIRKALTEEKRVSTKTSAADLVTETDHLVEDLIISELRERFPSHRFIAEEAAASGAKCVLTHSPTWIIDPI |
| Gene Sequence | WEECFQAAVQLALRAGQIIRKALTEEKRVSTKTSAADLVTETDHLVEDLIISELRERFPSHRFIAEEAAASGAKCVLTHSPTWIIDPI |
| Gene ID - Mouse | ENSMUSG00000024525 |
| Gene ID - Rat | ENSRNOG00000018516 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) | |
| Datasheet | Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) | |
| Datasheet | Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) |
| Citations for Anti IMPA2 pAb (ATL-HPA029561 w/enhanced validation) – 2 Found |
| Lin, Yuh-Feng; Chou, Jian-Liang; Chang, Jeng-Shou; Chiu, I-Jen; Chiu, Hui-Wen; Lin, Yuan-Feng. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma. Ebiomedicine. 2019;45( 31202813):220-230. PubMed |
| Ablimit, Tangnur; Tursun, Gulxan; Zhang, Yuanyuan; Abduxkur, Guzalnur; Abdurexit, Gulgina; Abliz, Guzalnur. Inositol monophosphatase 2 promotes epithelial ovarian cancer cell proliferation and migration by regulating the AKT/mTOR signaling pathway. Experimental And Therapeutic Medicine. 2022;24(5):668. PubMed |